Research Nomenclature Common Brand Names Researchers encountering semaglutide in published literature may find it referenced under commercial names including Ozempic (injectable, type 2 diabetes), Wegovy (injectable, weight management), and Rybelsus (oral tablet)
Reviews in endocrine & metabolic disorders, 15(3), pp.181187
A novel two-compartment model provided a general characterisation of semaglutide absorption following subcutaneous administration and of distribution and elimination across administration routes
Dapagliflozin primarily acts in the kidneys to increase urinary glucose excretion, addressing peripheral aspects of diabetes without directly targeting central nervous system pathways [24,25]
National Health and Nutrition Examination Survey 2017-March 2020 Prepandemic Data Files-Development of Files and Prevalence Estimates for Selected Health Outcomes